Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

(Abstracted from Reprod Biomed Online 2018;36:630–645) Sufficient luteal phase support (LPS) is essential during assisted reproductive technology (ART) cycles to improve implantation and pregnancy rates. The most common route for LPS in Europe is vaginal progesterone via capsule, gel, or tablet.

More information Original publication

DOI

10.1097/ogx.0000000000000610

Type

Journal article

Publisher

Ovid Technologies (Wolters Kluwer Health)

Publication Date

2018-10-01T00:00:00+00:00

Volume

73

Pages

581 - 581

Total pages

0